Affiliation: Vanderbilt University
- Baseline characteristics of participants in the African American Study of Kidney Disease and Hypertension (AASK) Clinical Trial and Cohort StudyMohammed Sika
Medicine, Vanderbilt, Nashville, TN, USA
Am J Kidney Dis 50:78-89, 89.e1. 2007....
- Blood pressure control, drug therapy, and kidney diseaseGabriel Contreras
University of Miami, Miami, FL, USA
Hypertension 46:44-50. 2005..These secondary analyses suggest a benefit of the low BP goal among patients assigned to amlodipine, but they must be interpreted cautiously...
- Quality of life in the African American Study of Kidney Disease and Hypertension: effects of blood pressure managementJames P Lash
University of Illinois, Chicago, IL 60612 7315, USA
Am J Kidney Dis 47:956-64. 2006..We examined effects of treatment-group assignment on health-related quality of life (HRQOL) measures and reported symptoms during 4 years of follow-up...
- Predictors of participant adherence and retention in the African American Study of Kidney Disease and HypertensionDeborah Brooks
Medical University of South Carolina, Charleston, SC, USA
Nephrol Nurs J 35:133-42. 2008....
- Validation of creatinine-based estimates of GFR when evaluating risk factors in longitudinal studies of kidney diseaseXuelei Wang
Cleveland Clinic Foundation, Department of Quantitative Health Sciences, Wb 4, 9500 Euclid Avenue, Cleveland, OH 44195, USA
J Am Soc Nephrol 17:2900-9. 2006....
- A randomized trial of a 6-week course of celecoxib on proteinuria in diabetic kidney diseaseMarvin Sinsakul
Rush University Medical Center, Chicago, IL 60607, USA
Am J Kidney Dis 50:946-51. 2007..The objective of this study is to compare the efficacy and safety of celecoxib with placebo for decreasing proteinuria in patients with diabetic nephropathy...